Abstract

BackgroundBone marrow stromal cells (BMSCs) are attractive as a source of neural progenitors for ex vivo generation of neurons and glia. Limited numbers of this subpopulation, however, hinder translation into autologous cell-based therapy. Here, we demonstrate rapid and efficient conditioning with hypoxia to enrich for these neural progenitor cells prior to further expansion in neurosphere culture.MethodAdherent cultures of BMSCs (rat/human) were subjected to 1 % oxygen for 24 h and then subcultured as neurospheres with epidermal growth factor (EGF) and basic fibroblast growth factor supplementation. Neurospheres and cell progeny were monitored immunocytochemically for marker expression. To generate Schwann cell-like cells, neurospheres were plated out and exposed to gliogenic medium. The resulting cells were co-cultured with purified dorsal root ganglia (rat) neurons and then tested for commitment to the Schwann cell fate. Fate-committed Schwann cells were subjected to in vitro myelination assay.ResultsTransient hypoxic treatment increased the size and number of neurospheres generated from both rat and human BMSCs. This effect was EGF-dependent and attenuated with the EGF receptor inhibitor erlotinib. Hypoxia did not affect the capacity of neurospheres to generate neuron- or glia-like precursors. Human Schwann cell-like cells generated from hypoxia-treated BMSCs demonstrated expression of S100β /p75 and capacity for myelination in vitro.ConclusionEnhancing the yield of neural progenitor cells with hypoxic preconditioning of BMSCs in vitro but without inherent risks of genetic manipulation provides a platform for upscaling production of neural cell derivatives for clinical application in cell-based therapy.Electronic supplementary materialThe online version of this article (doi:10.1186/s13287-016-0409-x) contains supplementary material, which is available to authorized users.

Highlights

  • Bone marrow stromal cells (BMSCs) are attractive as a source of neural progenitors for ex vivo generation of neurons and glia

  • Myelin-forming Schwann cells can be generated from hypoxia-treated BMSCs To test if signaling from rat dorsal root ganglion (DRG) neurons could drive human BMSC-derived Schwann cell-like cell (SCLC) to fate commitment as we reported for rat BMSC-derived SCLCs [6], the human BMSC-derived SCLCs were co-cultured with neurons purified from rat DRG

  • Hypoxic preconditioning of BMSC samples is a simple and efficient means of triggering increases in the nestinexpressing subpopulation of BMSCs prior to expansion in sphere-forming culture followed by directed differentiation along the neural lineage

Read more

Summary

Introduction

Bone marrow stromal cells (BMSCs) are attractive as a source of neural progenitors for ex vivo generation of neurons and glia Limited numbers of this subpopulation, hinder translation into autologous cell-based therapy. Mung et al Stem Cell Research & Therapy (2016) 7:146 sourced progenitor cells into animal models of spinal cord injury yielded dose-dependent improvements in outcome [9] This gave impetus to our pursuit of means to enrich for neural progenitors in the BMSC sample. Upregulation of EGF receptor (EGFR) was observed among neural stem cells that had been subjected to hypoxic conditions [12] It is unclear how neural progenitor cells located within the bone marrow niche respond to hypoxia

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.